Oliver FitzGerald

Oliver FitzGerald, MBBCh, BAO, MRCPI, MRCP, FRCPI, MD, is a consultant rheumatologist and Newman Clinical Research Professor at St Vincent's University Hospital and the Conway Institute, University College Dublin (UCD). Professor FitzGerald has published over 250 peer-reviewed papers, many on the subject of spondyloarthropathy. His main research interests include clinical and therapeutic studies; the development of novel imaging techniques; analysis of synovial and skin cellular and cytokine profiles; and, more recently, studies of gene and protein expression in diseased tissue. He currently receives research funding support from the Health Research Board and a number of pharmaceutical companies.

Latest contributions from Oliver FitzGerald

10-06-2020 | EULAR 2020 | Conference coverage | Video

EULAR 2020 highlights: Oliver FitzGerald

Oliver FitzGerald outlines his highlights from the psoriatic arthritis presentations at the EULAR 2020 E-Congress, and discusses what the study results mean for clinical practice (10:13).

12-11-2019 | Psoriatic arthritis | Video | Article

Expert commentary: The DISCOVER trials

Oliver FitzGerald comments on the findings from the DISCOVER-1 and DISCOVER-2 trials, which demonstrated the efficacy of guselkumab for the treatment of psoriatic arthritis (3:36).

01-11-2019 | Psoriatic arthritis | Podcast | Article

Discussing the guidelines for managing psoriatic arthritis: Part 2

In the second of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the implications and limitations of the recent ACR–NPF guidelines for the management of psoriatic arthritis, together with key clinical trials that have been published since the guidelines were released.

18-10-2019 | Psoriatic arthritis | Podcast | Article

Discussing the guidelines for managing psoriatic arthritis: Part 1

In the first of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the development of the recent ACR–NPF guidelines for the management of psoriatic arthritis, and the key differences between these and the EULAR and GRAPPA guidelines.